gulonolactone has been researched along with calcimycin in 1 studies
| Studies (gulonolactone) | Trials (gulonolactone) | Recent Studies (post-2010) (gulonolactone) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 35 | 0 | 5 | 11,946 | 40 | 444 |
| Protein | Taxonomy | gulonolactone (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boo, YC; Jo, H; Kim, HJ; Lee, DH; Lee, SI; Schellhorn, HE; Smith, D | 1 |
1 other study(ies) available for gulonolactone and calcimycin
| Article | Year |
|---|---|
Ascorbic acid synthesis due to L-gulono-1,4-lactone oxidase expression enhances NO production in endothelial cells.
Topics: Amino Acid Sequence; Animals; Ascorbic Acid; Biopterins; Blotting, Western; Calcimycin; Cattle; Cells, Cultured; Endothelial Cells; Gene Expression; Intracellular Fluid; Ionophores; L-Gulonolactone Oxidase; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Nitric Oxide; Nitric Oxide Synthase Type III; Plasmids; Sugar Acids; Transfection | 2006 |